Determining the stage of non–small-cell lung cancer often requires multiple preoperative tests and invasive procedures. Whole-body positron-emission tomography (PET) may simplify and improve the ...

Positron emission tomography (PET) has emerged as an indispensable tool in small animal imaging, bridging the gap between basic research and clinical applications.

Abstract Purpose: To prospectively evaluate the use of positron emission tomography with the glucose analog fluorodeoxyglucose (FDG-PET) to predict response to chemotherapy in patients with advanced ...

Contineum Therapeutics Initiates Patient Dosing in Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791 ...

A positron emission tomography (PET) scan is a type of imaging study that can help doctors see what’s happening inside your body and how it’s working. This can help them understand how a ...

The global positron emission tomography (PET) scanners market is expected to reach USD 1,441.5 million by 2025 and market is projected to steadily grow at a compound annual growth rate (CAGR) of 5.3%, ...

To the Editor: In their study of the value of positron-emission tomography (PET) in the preoperative staging of non–small-cell lung cancer, Pieterman et al. (July 27 issue)1 found that PET was ...